Tablets of sirolimus, used as an mTOR inhibitor in immunosuppressive therapy for transplant recipients in tertiary care hospitals. Suppliers provide to institutional buyers and distributors, purchased by transplant coordinators and pharmacy directors for renal and hepatic transplant management.